Expression analysis of MUC1, MUC16, and TAG72 on patient samples from various epithelial subtypes of ovarian cancer highlights antigen heterogeneity in this disease and demonstrates the aberrant expression pattern of cell-surface glycoproteins. This evidence concerns the gene MUC1 and ovarian carcinoma.